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A Twist Code Determines the
Onset of Osteoblast Differentiation
identification of genes regulating it specifically (Karsenty
and Wagner, 2002). Among them, Runx2 (formerly Cbfa1),
a cell-specific member of the Runx family of transcrip-
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classes of molecules. Some could be activators of tran-
scription whose expression is controlled by Runx2. Os-
terix, an osteoblast-specific zinc-finger protein, is suchSummary
a molecule (Nakashima et al., 2002). Others could be
inhibitors of Runx2 function that would be expressedRunx2 is necessary and sufficient for osteoblast differ-
transiently in osteoblast progenitors. Consistent withentiation, yet its expression precedes the appearance
the hypothesis that osteoblast differentiation may beof osteoblasts by 4 days. Here we show that Twist
negatively regulated, some skeletal dysplasias are char-proteins transiently inhibit Runx2 function during skel-
acterized by an increased bone formation (Mundlos andetogenesis. Twist-1 and -2 are expressed in Runx2-
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Twist proteins are basic helix-loop-helix (bHLH)-con-development, and osteoblast-specific gene expres-
taining transcription factors. Two Twist genes exist insion occurs only after their expression decreases.
vertebrates, Twist-1 and -2 (formerly dermo-1) (Wolf etDouble heterozygotes for Twist-1 and Runx2 deletion
al., 1991; Li et al., 1995). Gene deletion experiments havehave none of the skull abnormalities observed in
shown that Twist-1 is required for closure of the neuralRunx2/ mice, a Twist-2 null background rescues the
clavicle phenotype of Runx2/ mice, and Twist-1 or -2 tube during mouse development (Chen and Behringer,
deficiency leads to premature osteoblast differentia- 1995), while mice homozygous for a Twist-2 null allele
tion. Furthermore, Twist-1 overexpression inhibits os- show elevated expression of proinflammatory cytokines
teoblast differentiation without affecting Runx2 ex- causing perinatal death. Twist-1 and -2 repress cytokine
pression. Twist proteins’ antiosteogenic function is gene expression by inhibiting RelA transactivation func-
mediated by a novel domain, the Twist box, which tion through an undefined mechanism (Sosic et al.,
interacts with the Runx2 DNA binding domain to inhibit 2003). Additionally, Twist-1/ mice present a craniosyn-
its function. In vivo mutagenesis confirms the antios- ostosis phenotype such as an increased bone formation
teogenic function of the Twist box. Thus, relief of inhi- in cranial sutures. The same is true in Saethre-Chotzen
bition by Twist proteins is a mandatory event preclud- patients (El Ghouzzi et al., 1997; Howard et al., 1997)
ing osteoblast differentiation. who are heterozygous for Twist-1 inactivation. This latter
observation raises the hypothesis that Twist-1 and pos-
sibly Twist-2 could inhibit osteoblast differentiation byIntroduction
inhibiting Runx2 function.
Here we show that Twist proteins transiently inhibitMolecular understanding of osteoblast differentiation
osteoblast differentiation during skeletogenesis throughhas made major progress in the last few years with the
the interaction of a novel domain in these proteins and
Runx2 DNA binding domain. These results reveal an unan-
ticipated complexity in osteoblast differentiation whose*Correspondence: karsenty@bcm.tmc.edu
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Results inactivation and analyzed their skeletal phenotypes us-
ing alcian blue/alizarin red staining of skeletal prepara-
tions. Runx2/ mice have delayed closure of the fonta-Comparison of Twist-1, -2, and Runx2 Expression
during Osteoblast Differentiation nelles due to a delay in osteoblast differentiation (Otto
et al., 1997), whereas Twist-1/ mice have larger intra-To ascertain whether Twist-1 expression in the develop-
ing skeleton was compatible with a role as an inhibitor parietal bones and premature fusion of the coronal su-
tures (Figure 2A) (El Ghouzzi et al., 1997; Howard et al.,of osteoblast differentiation, we performed in situ hy-
bridization analysis comparing expression of Twist-1, 1997). In contrast, mice heterozygous for Twist-1 and
Runx2 inactivation have a normally shaped skull, intra-Runx2, and Bone sialoprotein (Bsp), a marker of differen-
tiated osteoblasts (Bianco et al., 1991; Chen et al., 1992) parietal bones of nearly normal size, and no premature
fusion of their coronal sutures (Figures 2A and 2B). These(Figure 1). Given the craniosynostosis phenotype of the
Twist-1/ mice, we focused this analysis on the devel- observations reveal a genetic interaction between Twist-1
and Runx2 during development of the skull, a part ofoping skull. At E12, Runx2 was expressed in cells of the
future temporal and parietal bones but not in any other the skeleton whose ossification does not require chon-
drogenesis. There was no rescue of the hypoplasticcells of the developing skull (Figure 1A). In contrast,
Twist-1 was strongly expressed in Runx2-expressing clavicle phenotype, another feature of Runx2/ mice,
indicating that Twist-1 alone does not affect osteoblastcells of the presumptive temporal and parietal bones
and also in cells of the future frontal and occipital bones differentiation in this skeletal element (Figure 2A).
Twist-2 haploinsufficiency did not correct the skeletalwhere Runx2 was not yet expressed (Figure 1B). At that
stage, Bsp expression could not be detected (Figure abnormalities of Runx2/ mice, while mice homozygous
for Twist-2 deletion and heterozygous for Runx2 in-1C). At E13, Runx2 expression had increased in intensity
in cells of the temporal and parietal bones and was also activation (n  6) had a near-complete rescue of the
clavicle hypoplasia characteristic of Runx2/ mice (Ottodetectable in cells of the future occipital bone, while
Twist-1 expression was still high in most cells of the et al., 1997) (Figure 2C). These mice were analyzed at
birth, since the Twist-2 mutation is lethal thereafterpresumptive skull. Bsp was expressed in a small area
of the temporal bone in cells expressing Runx2 but not (Sosic et al., 2003). Twist-2 deletion did not affect the
skull abnormalities observed in Runx2/ mice, and thisTwist-1 (Figure 1, compare 1D–1F). At E14, Runx2 was
highly expressed in cells of the future temporal, parietal, is consistent with the fact that Twist-2 and Runx2 are
not coexpressed in the developing skull (data notand occipital bones (Figure 1G), while Twist-1 expres-
sion was now of weaker intensity throughout the skull shown).
(Figure 1H). Following this decrease in Twist-1 expres-
sion, Bsp expression was detected in all Runx2-express- Premature Osteoblast Differentiation in Absence
ing cells of the temporal and parietal bones (Figure 1I). A of Twists’ Expression
higher magnification analysis showed that Bsp-expressing The pattern of Twist-1 and -2 expression during osteo-
cells expressed Runx2 but not Twist-1 (Figures 1J–1L). blast differentiation and the rescue of the Runx2 haploin-
At E15, Runx2 expression had become stronger and sufficiency phenotype by Twists’ inactivation support
broader, while Twist-1 expression was now markedly the hypothesis that Twist-1 and -2 inhibit osteoblast
decreased (Figures 1M and 1N). Bsp expression was differentiation. To determine if that is the case, we ana-
higher in cells of the parietal and temporal bones in which lyzed skulls of Twist-1/ embryos using mineralized
Twist-1 expression was low and Runx2 expression high trabeculae and Osteocalcin-expressing cells as indica-
(Figures 1M–1O). tors of differentiated osteoblasts in this structure ossi-
The similarity of sequence between Twist-1 and -2 fying through an intramembranous process. In E15 em-
prompted us to compare Twist-2, Runx, and Bsp expres- bryos, there were virtually no mineralized trabeculae in
sion in the developing skeleton. At E12 and E13, Twist-2 wild-type (wt) future parietal bone. In contrast, they were
was coexpressed with Runx2 in cells of the developing already present in Twist-1/ parietal bones and ex-
fore- and hindlimbs, the ribs, and vertebrae (Figures 1P tended toward the midline (Figures 3Ba and 3Bb). Osteo-
and 1Q and data not shown). At that stage, we could not calcin was not expressed in E15 wt parietal bone at
detect Bsp expression in any of these skeletal elements that stage, while it was already detectable in Twist-1/
(Figure 1R and data not shown). In contrast, at E14, parietal bone and extended toward the midline (Figures
Twist-2 expression has disappeared in Runx2-express- 3Be and 3Bf). At E16, mineralized trabeculae were pres-
ing cells of the forelimbs, ribs, and vertebrae where ent in both wt and Twist-1/ parietal bones; however,
Bsp expression was now detected, indicating that os- they extended significantly further toward the midline
teoblast differentiation has occurred (Figures 1S–1U and in Twist-1/ than in wt parietal bones (Figures 3Bc and
data not shown). Taken together, these data suggest 3Bd). There was expression of Osteocalcin in a small
that osteoblast differentiation occurs only after Twist area of the wt parietal bones, while the zone of Osteocal-
gene expression decreases. cin-expressing cells extended further toward the midline
in Twist-1/ embryos (Figure 3Bg and 3Bh). At P2, min-
eralized trabeculae had now reached the midline sutureGenetic Interaction between Twists and Runx2
To assess if there was a genetic interaction between in Twist-1/ but not in wt skulls (Figures 3Ca and 3Cb).
Likewise, Osteocalcin expression could be detectedTwist genes and Runx2, we generated mice heterozy-
gous for both Twist-1 and Runx2 inactivation or homozy- on both sides of the suture and reached the midline
in P2 Twist-1/ but not in wt skulls (Figures 3Cc andgous for Twist-2 inactivation and heterozygous for Runx2
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Figure 1. Twist-1 and Twist-2 Expression during Osteoblast Differentiation
(A–O) In situ hybridization for Twist-1, Runx2, and Bsp during skull development. Adjacent sections of heads of E12 (A–C), E13 (D–F), E14
(G–L), and E15 (M–O) embryos were hybridized with Runx2 (A, D, G, J, and M), Twist-1 (B, E, H, K, and N), or Bsp (C, F, I, L, and O) probes.
As Twist-1 expression declines in the developing bones of the skull, Bsp expression becomes detectable. Brackets indicate the regions within
the parietal and temporal bones expressing Bsp. Arrows within the higher magnification of E14 skulls indicate areas expressing Runx2 and
Bsp but not Twist-1. On the right, schematic representation of skulls at each time point indicates the developing bones as follows: green,
frontal; yellow, parietal; red, temporal; and purple, occipital. Asterisks mark areas with detectable Bsp expression. (P–U) Analysis of Runx2,
Twist-2, and Bsp expression during development. Adjacent sections of ribs (P–U) at E13 (P–R and V–X) and at E14 (S–U and Y–AA). Bsp
expression is only detected in the ribs once Twist-2 expression disappears. Magnification: 50-fold, (A)–(I) and (P)–(U); 200-fold, (J)–(L); and
25-fold, (M)–(O).
3Cd). These findings and the expression pattern of indicate that Twist-1/haploinsufficiency results in pre-
mature osteoblast differentiation in the skull, which inOsteocalcin in wt and Twist-1/ developing frontal
bones (see Supplemental Figure S1A at http://www. turn leads to premature suture closure.
We also analyzed E14 wt and Twist-2 null embryos.developmentalcell.com/cgi /content /full /6 /3 /423/DC1)
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Figure 2. Twist-1 and -2 Interact Genetically with Runx2
(A) Alizarin red/alcian blue-stained preparations of the skull and clavicles from 10-day-old wt, Runx2/, Twist-1/, and Runx2/; Twist-1/
mice. Runx2/ mice display a delay in closure of the fontanelles (arrows) and a decrease in the size of the intraparietal bone and hypoplastic
clavicles. Twist-1/ mice display craniosynostosis, that is, increased growth of several bones and fusion of the coronal sutures (arrows).
Mice heterozygous for both Runx2 and Twist-1 deletions have a normal skull. Twist-1 haploinsufficiency does not rescue the clavicle hypoplasia
of Runx2/ mice.
(B) Width of the intraparietal bones and the percentage of mice with fused coronal sutures in 10-day-old wt, Runx2/, Twist-1/, and
Runx2/; Twist-1/ mice. In Runx2/; Twist-1/ mice, the intraparietal bone was close to normal size, and the coronal suture phenotype
of Twist-1/ mice was completely rescued (p  0.02 for all parameters).
(C) Alizarin red/alcian blue-stained preparations of skulls and clavicles from newborn pups wt, Runx2/, Twist-2/, and Runx2/; Twist-2/
mice. Note the rescue of the hypoplastic clavicle in Runx2/; Twist-2/ mice, while the skull abnormalities of Runx2/ mice were not corrected.
Osteocalcin expression was undetectable in the E14 wt ribs in E14 Twist2 null but not in wt embryos. Further-
more, there was evidence of vascular invasion, as shownskeletal elements examined but was present in cells of
the developing ribs and clavicles of Twist-2 null embryos by the presence of red blood cells in E14 Twist-2 null
ribs but not in wt embryos (Figures 3De and 3Df). Thus,(n  3) (Figures 3Da–3Dd). Consistent with this pattern
of Osteocalcin expression, histological analysis of adja- Twist-2 inhibits osteoblast differentiation in skeletal ele-
ments ossifying through intramembranous (clavicles) orcent sections showed typical cuboidal osteoblasts orga-
nized in bone collar-like structures around developing endochondral mechanism (ribs).
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Figure 3. Twist-1 or Twist-2 Inhibits Osteoblast Differentiation
(A) Schematic illustration of the skull plans of section.
(B) Equivalent sections of E15 (Ba, Bb, Be, and Bf) and E16 skulls (Bc, Bd, Bg, and Bh) from wt (Ba, Bc, Be, and Bg) and Twist-1/ (Bb, Bd,
Bf, and Bh) embryos were analyzed for mineralized bone by von Kossa staining (Ba–Bd) and Osteocalcin expression (Be–Bh). E15 and E16
Twist-1/ skulls had a broader area of mineralized trabeculae and more Osteocalcin-expressing cells than wt skulls. Brackets encompass
areas of mineralized bone. Magnification: 100-fold, (Ba)–(Bd); 50-fold, (Be)–(Bh).
(C) Equivalent sections of P2 wt (Ca and Cc) and Twist-1/ (Cb and Cd) skulls analyzed as above. Twist-1/ skulls show a broader zone of
mineralized bone and of Osteocalcin-expressing cells. Magnification: 100-fold, (Ca)–(Cd).
(D) Equivalent sections of E14 wt (Da and Dc) and Twist-2 null (Db and Dd) embryos were analyzed for Osteocalcin expression. Osteocalcin
was expressed in clavicles (Db) and ribs (Dd) of Twist-2 null but not of wt embryos. Hematoxylin and eosin staining of E14 wt (De) or Twist-2 null
(Df) ribs. Note the presence of cuboidal osteoblast-like shape of the Osteocalcin-expressing cells (arrowhead). The presence of red blood
cells (arrow) indicates initiation of vascular invasion in these skeletal elements. Magnification: 400-fold, (Da) and (Db); 200-fold, (Dc) and (Dd);
and 800-fold, (De) and (Df).
Twist-1 Inhibits Osteoblast Differentiation without cells, while expression of 1(I) Collagen and Tnap was
not affected (Figure 4B). This gene expression profileAffecting Runx2 Expression
Next, we asked whether Twist proteins affect osteoblast is reminiscent of the one observed in mesenchymal
cells not yet committed to the osteoblast lineage (Aubindifferentiation with or without affecting Runx2 expres-
sion. We first analyzed Runx2 expression in Twist-1/ and Triffitt, 2002). Importantly, Runx2 expression was
not affected in Twist-1-overexpressing ROS 17/2.8 cellsembryos and failed to detect any difference in the ex-
pression of this gene between mutant and wild-type (Figure 4B). Overexpression of a deletion mutant of
Twist-1 lacking bHLH and C-terminal domains, NTwist, didembryos at all time points analyzed (Figure 4A). Next,
we permanently transfected ROS 17/2.8 osteoblastic not affect osteoblast gene expression in ROS 17/2.8
cells, indicating that the N terminus of Twist-1 has nocells with Twist-1 expression vectors. ROS 17/2.8 cells
express genes characteristic of osteoblast progenitors, antiosteogenic function (Figure 4B). Conversely, in os-
teoblasts isolated from Twist-1/ calvariae, there wassuch as Type I collagen and Tissue nonspecific alkaline
phosphatase (Tnap), and genes that define the differenti- an increase in expression of Osteocalcin and Bsp, a
gene not expressed in ROS 17/2.8 cells, while expres-ated osteoblast phenotype, such as Osteocalcin, an os-
teoblast-specific gene whose expression is regulated sion of Tnap,1(I) Collagen, and Runx2 was not modified
(Figure 4C). This pattern of expression is a mirror imageby Runx2 (Ducy et al., 1997). Osteocalcin expression
was decreased in Twist-1-overexpressing ROS 17/2.8 of the one described in Twist-1-overexpressing ROS 17/
Developmental Cell
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Figure 4. Inhibition of Osteoblast Differentia-
tion with Normal Runx2 Expression
(A) In situ hybridization showing unchanged
Runx2 expression in E12 (Aa), E13 (Ab), and
E14 (Ac) Twist-1/ embryos compared to wt
embryos (compare to Figures 1A, 1D, and 1G).
(B) Northern blot analysis of total RNA iso-
lated from ROS 17/2.8 cells permanently trans-
fected with empty vector, Twist-1, or NTwist ex-
pression vectors. The blot was sequentially
hybridized with probes for Twist-1, Osteocal-
cin, Tnap, 1(I) Collagen, Runx2, and Gapdh
as a control. Note the decreased Osteocalcin
expression in Twist-1-expressing but not in
NTwist-expressing cells. Tnap, 1(I) Collagen,
and Runx2 expression were not affected.
(C) Northern blot analysis of RNA isolated
from Twist-1/ or wt calvarial cells. Twist-1/
cells show increase in Osteocalcin and Bsp
without affecting Runx2 expression.
2.8 cells. Taken together, these two experiments indi- The Twist Box as an Antiosteogenic Domain
To identify the domains within Twist proteins responsi-cate that Twist-1 affects osteoblast differentiation as
defined by osteoblast-specific gene expression without ble for the inhibition of Runx2 function, we used Twist-1
deletion mutants in DNA cotransfection assays. All dele-affecting Runx2 expression. Additionally, the analysis
of Twist-1/ cells further supports the contention that tion mutants contained Twist-1’s N terminus (NTwist), a
domain that has no detectable effect on osteoblast geneinhibition of osteoblast differentiation by Twist-1 does
not require the presence of chondrocytes, since osteo- expression (Figures 4B) but that comprises Twist-1’s
nuclear localization signal (NLS) (Hamamori et al., 1999).blasts in the skull appear through an intramembra-
NBTwist, containing Twist-1’s basic domain, failed to in-nous mechanism.
hibit Runx2 transactivating function (Figure 5E). Like-
wise, NBHTwist, a Twist-1 molecule containing the entire
bHLH domain, did not affect Runx2’s transactivationTwist Proteins Inhibit Runx2
Transactivation Function function (Figure 5E). A single amino acid substitution
Twist-1 mutant that has lost its ability to heterodimerize,To determine whether Twist proteins inhibit osteoblast
differentiation by inhibiting Runx2 function, we per- H2ProTwist (Spicer et al., 1996), still inhibited Runx2-trans-
activating function. These experiments establish thatformed DNA cotransfection experiments in COS7 cells
that do not express Twist-1 or -2, Runx2, or any osteo- Twist-1 bHLH domain is dispensable for the antios-
teogenic function of this protein. In contrast, NCTwist, ablast-specific gene (data not shown). Transfection of a
Runx2 expression vector increased 100-fold the activity deletion mutant containing only Twist-1’s N and C ter-
mini, inhibited Runx2 transactivating function even moreof an artificial promoter containing six Runx2 binding
sites upstream of a luciferase (Luc) gene (p6OSE2-Luc) efficiently than wt Twist-1, indicating that the antios-
teogenic function of Twist-1 resides in its C terminus(Figure 5A). Introduction of Twist-1 or -2 expression vec-
tors in this assay decreased Runx2-dependent Luc ac- (Figure 5E). Further deletions revealed that Twist-1’s
antiosteogenic function is comprised in the sequencetivity by 80% (Figure 5A). The inhibitory effect of Twist-1
on Runx2 transactivation function occurred in a dose- from amino acids 186 to 206 (Figure 5E). This domain
is conserved in Twist-2, and Twist-1 and -2 are the onlydependent manner (Figure 5B). Twist-1 could also inhibit
Runx2 function when using the native Osteocalcin pro- proteins containing this sequence. We called this antios-
teogenic domain the Twist box (Figure 6A).moter-Luc chimeric gene (Figure 5C). Twist protein inhi-
bition of Runx2 transactivation function was specific, We also searched for Runx2 domains interacting with
Twist proteins. All deletion mutants of Runx2 used insince neither a zinc finger protein (Sp1) nor a leucine
zipper protein (CREB) affected Runx2 transactivation DNA transfection and immunoprecipitation experiments
contained Runx2’s NLS (Thirunavukkarasu et al., 1998).function in this assay (Figure 5A). Conversely, Twist-1
did not affect Sp1’s or CREB’s ability to transactivate To test whether the DNA binding domain, or Runt do-
main, of Runx2 interacts with Twist proteins, we usedtheir respective reporter constructs (Figure 5D).
Osteoblast Differentiation and Twist
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Figure 5. Twist-1 and -2 Inhibit Runx2 Transactivation Activity
(A–F) DNA cotransfection experiments. (A) p6OSE2-Luc reporter construct and Runx2 expression vector were transiently cotransfected alone
or with expression vectors for HA-Twist-1, HA-Twist-2, Sp1, or CREB. Twist proteins inhibited Runx2 transactivation function, while Sp1 and
CREB did not. (B) p6OSE2-Luc reporter construct and Runx2 expression vector were transiently cotransfected with different amounts of
HA-Twist-1 expression vector. Twist-1 inhibited Runx2 transactivation in a dose-dependent manner. (C) pOG2-reporter construct containing
only one OSE2 site and a Runx2 expression vector were transiently transfected with HA-Twist-1. Twist-1 inhibits Runx2 transactivation function
when using a native OG2 promoter containing only one OSE2 site. (D) COS7 cells were transfected with either Sp1-responsive element-Luc
or CREB-responsive element-Luc reporter constructs in the absence and presence of HA-Twist-1 expression vector. Fold activity was measured
in the absence of HA-Twist-1 and set at 100%. Twist-1 did not decrease the transactivation activity of endogenous Sp1 or CREB on their
respective Luc-reporter constructs. (E) p6OSE2-Luc reporter was transiently transfected along with Runx2 expression vectors and the indicated
expression vectors for HA-Twist-1. Above, schematic diagrams of Twist-1 and Twist-1 mutants. Full-length Twist, NCTwist, and NC186-206 inhibited
Runx2 transactivating function. (F) p6OSE2-Luc reporter was transiently transfected along with Runx2, RGR, or Runx1 and the expression
vectors for Twist-1. Above, schematic diagrams of Runx2, RGR, and Runx1. Twist-1 did not inhibit the transactivation activity of RGR, in
which the Runx2 DNA binding domain was replaced with Gal4 DNA binding domain. Twist-1 inhibited Runx1 transactivation activity. Numbers
indicate percentage homology between Runx1 and Runx2 in the N-terminal, Runt, and C-terminal domains. Lower panels in (A) and (C)–(F),
Western blots of nuclear extracts from transfected cells showing the expression of the desired proteins. Values were expressed as percentage
of the activity of 6OSE2-Luc or OG2-Luc with Runx2 alone.
a UAS-reporter gene and a chimeric protein (RGR), in Twist-1 or -2 or Twist-1-deletion mutants and Flag-
tagged Runx2 or Runx2-deletion mutants, nuclear ex-which Runx2’s DNA binding domain was replaced by a
Gal4 DNA binding domain (Lorch and Kornberg, 1985). tracts prepared, and immunoprecipitations performed.
As suggested by the DNA cotransfections, Runx2 immu-RGR transactivated the UAS-Luc vector, but Twist-1
could not abrogate this transactivating function, strongly noprecipitated Twist-1 and -2. It also immunoprecipi-
tated NCTwist and NC186-206 but not NTwist, NBTwist, or NBHTwistsuggesting that the Runt domain interacts with Twist
proteins (Figure 5F). To assess whether other domains of (Figure 6B, left panel). Conversely, Twist-1 and NC186-206
immunoprecipitated Runx2 and its Runt domain but didRunx2 were targets of Twist-1’s antiosteogenic function,
we replaced Runx2 in this assay with Runx1, a member not immunoprecipitate NQA, a Runx2 deletion mutant
containing its N-terminal and QA domains, or PST, con-of the Runx family that shares high homology with Runx2
only in its Runt domain (Bae et al., 1993). Twist-1 de- taining only the C-terminal PST domain (Figure 6B, mid-
dle and right panels). These experiments establish that,creased Runx1 transactivation activity nearly as well
as it affected Runx2 function (Figure 5F). These results in the conditions of this assay, the Runt domain is an
essential part and perhaps the only domain of Runx2indicate that the Runt domain is the main if not only
domain in Runx2 interacting with the Twist box present interacting with the Twist box. This interaction could
occur in vivo as endogenous Runx2 immunoprecipitatedin both Twist proteins.
Twist-1 and endogenous Twist-1 immunoprecipitated
Runx2 in osteoblasts (Figure 6C). Last, in a cell-freeInhibition of Runx2 DNA Binding Function
by the Twist Box system, GST-Runx2 but not GST-CREB pulled down
His-Twist-1, establishing that Twist-1 and Runx2 canTo determine whether Twist proteins and Runx2 interact
physically, COS7 cells were transfected with HA-tagged interact directly (Figure 6D). In control experiments,
Developmental Cell
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Figure 6. Identification of Twists’ Antiosteoge-
nic Domain
(A) Immunoprecipitation assays. COS7 cells
were transiently transfected with expression
vectors for Flag-Runx2, deletion mutants of
Flag-Runx2, HA-Twist-1, HA-Twist-2, and de-
letion mutants of HA-Twist-1. Nuclear ex-
tracts were immunoprecipitated with anti-
Flag antibody and then immunoblotted with
anti-HA antibody. Twist-1 molecules con-
taining the last 20 amino acid C-terminal do-
main interacted specifically with the DNA
binding domain of Runx2. Below, 20 g of
input samples was immunoblotted with anti-
Flag or anti-HA antibody.
(B) Runx2 interacted with Twist-1 in osteo-
blasts. Osteoblast nuclear extracts were im-
munoprecipitated with either anti-Twist-1 or
anti-Runx2 antibodies and then analyzed by
Western blot assays using anti-Runx2 or anti-
Twist-1 antibodies. As controls, nuclear ex-
tracts were also incubated with Protein A
Sepharose alone.
(C) Pull-down assays. GST-Runx2, GST-
CREB, or buffer alone were incubated with
His-Twist-1 or His-NTwist and then incubated
with glutathione beads. Eluates from the
beads were immunoblotted with anti-HA anti-
body. Only GST-Runx2 and His-Twist-1
showed direct interaction. Efficiency was de-
termined by quantification of the amount of
Twist-1 bound to the beads corrected by the
amount of Runx2 bound.
(D) Gel retardation assay. Recombinant GST-
Runx2 and His-Twist-1 (lane 3), His-NTwist (lane
4), His-NC186-206 (lane 5), or His-CREB (lane 6)
was incubated with labeled OSE2 oligonucle-
otides. His-Twist-1 and His-NC186-206 decreased
Runx2 DNA binding, while His-NTwist and His-
CREB did not.
(E) Gel retardation assay. Nuclear extracts
isolated from wt (lanes 1 and 3) and Twist-
1/ calvarial cells (lanes 2 and 4) were
incubated with either labeled OSE2 (lanes 1 and 2) or Sp1 oligonucleotides (lanes 3 and 4). Twist-1/ cells demonstrated increased Runx2
binding compared to wt while Sp1 binding to an Sp1 oligonucleotide appeared equal.
Twist did not immunoprecipitate Osx, Sp1, or CREB Chaplin (CC/), obtained through a screen for N-ethyl-
N-nitrosourea (ENU)-induced dominant mutations (Jus-(data not shown).
The ability of Twist proteins to interact with Runx2’s tice, 2000), harbored a hindlimb polydactyly. Molecu-
larly, the CC mutation is caused by a single amino acidRunt domain implied that they should inhibit Runx2 DNA
binding function. In gel retardation assays, Twist-1 and substitution mutation (Ser192Pro) in the Twist box of
Twist-1 (Figure 7A). In an immunoprecipitation assay,-2 markedly decreased binding of Runx2 to its cognate
binding site, while NTwist did not. NC186-206 was even more CC mutant protein interacted poorly with Runx2 (Figure
7B). Moreover, CC/ mice have a craniosysnostosisefficient than Twist-1 in preventing Runx2 from binding
to DNA (Figure 6E, lanes 1–5). This inhibition was spe- phenotype with irregular lamboidal and coronal suture
lines (Figure 6C). This skeletal phenotype and the bio-cific, as CREB did not inhibit Runx2’s binding to DNA.
Conversely, Twist-1 did not inhibit CREB binding to DNA chemical data established that the CC/ mutation is a
loss-of-function allele for Twist box function. We then(Figure 6E, lane 6, and data not shown). In the reverse
experiment, nuclear extracts of Twist-1/ osteoblasts generated CC/CC mice that died immediately after birth.
At E16, CC/CC displayed short limbs and polydactylyshowed increased binding ability to the Runx2 binding
site but not to an Sp1 binding site (Figure 6F). Thus, of the hindlimbs but no overt neural tube defect (data not
shown). This contrasts with what was observed followingthe physical interaction between the Twist box of Twist
proteins and the Runx2 Runt domain decreases Runx2’s deletion of the entire gene (Chen and Behringer, 1995).
To determine the role of serine 192 in osteoblast differ-ability to bind to DNA and thereby its transactivation
ability. entiation, we performed histological and gene expres-
sion analysis using Osteocalcin as a marker of differenti-
ated osteoblasts in wt and CC/CC embryos from E14In Vivo Mutagenesis of the Twist Box Leads
to Premature Osteoblast Differentiation to E18. Histological analysis of E14 CC/CC ribs showed
no obvious differences compared to wt embryos. AtWe next tried to obtain in vivo confirmation of the Twist
box function. A mouse mutant strain called Charlie E15, however, a thicker bone collar was consistently
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Figure 7. In Vivo Mutagenesis of the Twist Box
(A) Genomic sequencing of wt and Charlie Chaplin heterozygote (CC/) Twist-1 alleles showing a T → C base-pair change in CC/ Twist-1
resulting in a Ser192Pro mutation in the Twist box.
(B) Coimmunoprecipitation. COS7 cells were cotransfected with Flag-tagged Runx2, HA- tagged Twist-1, and a cc-Twist-1 allele. Flag-Runx2
immunoprecipitated cc-Twist-1 poorly compared to Twist-1.
(C) Alcian blue/alizarin red staining of P10 skulls from wt and CC/ mice. Note the closed sutures in CC/ skulls (arrows).
(D) Histological analysis of E14 (Da, De, Di, and Dm), E15 (Db, Df, Dj, and Dn), E16 (Dc, Dg, Dk, and Do), and E18 ribs (Dd, Dh, Dl, and Dp)
from wt (De–Dh and Dm–Dp) and CC/CC embryos (Da–Dd and Di–Dl). Note the presence of a thicker bone collar in E15 and E16 CC/CC
compared to wt ribs. Note the presence of bone trabeculae in E16 CC/CC and E18 wt ribs. Magnification: 50-fold, (Dc), (Dd), (Dg), and (Dh);
100-fold, (Da), (Db), (De), and (Df); 200-fold, (Dk), (Dl), (Do), and (Dp); and 400-fold, (Di), (Dj), (Dm), and (Dn).
(E) In situ hybridization for Osteocalcin of E14 (Ea and Ed), E15 (Eb and Ee), and E16 (Ec and Ef) on equivalent sections from wt (Ed–Ef) and
CC/CC (Ea–Ec) embryos. Osteocalcin is expressed as early as in E15 CC/CC ribs. Magnification: 50-fold, (Ea)–(Ef).
observed in CC/CC compared to wt ribs (Figures 7Db, and contained in their center bone trabeculae, indicating
that bone formation was advanced (Figures 7Dc and7Df, 7Dj, and 7Dn). Based on histological appearance,
E15 CC/CC ribs looked more like E16 than E15 wt ribs. 7Dk). In comparable sections, the bone collar was con-
sistently thinner, and there were no bone trabeculae inE16 CC/CC ribs were surrounded by a thick bone collar
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the diaphysis of E16 wt ribs (Figures 7Dg and 7Do). At The Twist Box as an Antiosteogenic Domain
Several lines of evidence indicate that Twist proteinsE18, wt and CC/CC ribs resembled each other, although
CC/CC ribs had a thicker bone collar and consistently inhibit osteoblast differentiation by interfering with
Runx2 function. First, expression of molecular markerscontained more trabeculae (Figures 7Dd, 7Dh, 7Dl, and
7Dp). Consistent with what was observed histologically, of differentiated osteoblasts in Runx2-expressing cells
is not detectable as long as Twist genes are expressedOsteocalcin expression could be detected as early as
E15 in CC/CC ribs. In contrast, Osteocalcin expression in these cells. Second, mice heterozygotes for Twist-1
and Runx2 deletions have a normal skull, and doublewas absent in wt E15 and 16 ribs (Figure 7E).
Since chondrocyte hypertrophy is a mandatory event mutants for Twist-2 and Runx2 have normal clavicles.
Third, Twist proteins and Runx2 physically interact, andpreceding osteoblast differentiation, we analyzed chon-
drocyte differentiation in wt and CC/CC ribs from E14 this interaction affects Runx2 DNA binding function. Mo-
lecular and genetic evidence establishes that Twists’to E18 using as molecular markers1(II) collagen for prolif-
erating chondrocytes, IndianHedgehog (Ihh) for prehyper- antiosteogenic function is exerted by a 20 amino acid-
long domain, the Twist box, a domain distinct from theirtrophic chondrocytes, and 1(X) collagen for hypertro-
phic chondrocytes. At E14, 1(II) collagen and Ihh bHLH domains. In vitro, only the Twist-1 deletion mu-
tants that contain the Twist box interact with Runx2. Inexpression were virtually identical in wt and CC/CC ribs,
and the same was true for these markers at all stages cell culture, a deletion mutant of Twist-1 containing its
N-terminal domain and the Twist box inhibited Runx2analyzed (Figures 8Aa–8Ap). In contrast, we observed
a slight increase in 1(X) collagen expression intensity transactivating function, and a single amino acid substi-
tution in the Twist box of Twist-1 results in prematurein E14 CC/CC ribs compared to wt ribs, suggesting that
chondrocyte hypertrophy was advanced in the mutant osteoblast differentiation in vivo. Interestingly, the Twist
box is more highly conserved in vertebrates than inribs. At E15, the same increase in 1(X) collagen expres-
sion was noticeable in the CC/CC compared to wt ribs invertebrates (Castanon and Baylies, 2002).
(Figures 8Ar and 8Av). At E16, 1(X) collagen expression
had increased noticeably in wt ribs, while it had markedly Twist Box and Saethre-Chotzen Syndrome
decreased in CC/CC ribs (Figures 8As and 8Aw). At E18, Although there is no mutational hot spot in Twist-1 (Gripp
these three genes were not expressed anymore in wt et al., 2000), nearly half of the mutations result in prema-
and CC/CC ribs (Figures 8Ad, 8Ah, 8Al, 8Ao, 8As, and ture termination before the Twist-1 C-terminal domain
8Ax). Thus, there is an acceleration of endochondral or are frameshift mutations. The absence of any Twist
ossification in CC/CC ribs marked by a premature in- box in this class of mutation could easily explain the
crease in 1(X) collagen expression leading the way to occurence of the disease. Another group of Saethre-
premature osteoblast differentiation. Chotzen mutations are missense mutations that do not
The advance in chondrocyte hypertrophy observed in affect the Twist-1 C terminus. The existence of this type
CC/CC embryos led us to analyze Twist-1 expression of mutation, along with recent studies using transformed
in wt developing ribs from E13 to E15. At those stages, cells obtained from a Saethre-Chotzen patient and
Twist-1 was expressed in Runx2- and subsequently showing an increase in Osteocalcin expression (Elanko
Bsp-expressing cells of the perichondrium/bone collar et al., 2001), suggests that more than one mechanism
but never above background level in presumptive chon- may be at work to cause Saethre-Chotzen Syndrome.
drocytes in the center of the ribs (data not shown). This However, the contention that the antiosteogenic func-
observation is in agreement with the notion that cells tion of the Twist box is conserved in human is supported
of the perichondrium inhibit chondrocyte hypertrophy, by the fact that human Runx2 and human Twist-1 can
a process itself dependent in part on Runx-2 expression interact physically (see Supplemental Figure S1B at http://
(Long and Linsenmayer, 1998; Di Nino et al., 2001; www.developmentalcell.com/cgi/content/full/6/3/423/
Takeda et al., 2001; Ueta et al., 2001), and indicates that DC1) and by the existence of a Saethre-Chotzen-caus-
Twist-1 is a mediator of this negative regulation of the ing mutation that leaves intact Twist-1’s bHLH domain
later phases of endochondral ossification. but removes its Twist box (Gripp et al., 2000). Interest-
ingly, this mutation causes a more severe form of the
disease, with limb patterning defects similar to the ones
Discussion observed in CC/CC mice.
This study reveals that osteoblast differentiation is a The Twist Code as the Earliest Regulator
negatively regulated process early during skeletogen- of Osteoblast Differentiation
esis, despite a normal expression of Runx2 (Figure 8B). Histologic and gene expression analyses of Twist-1-
The interaction between Runx2’s DNA binding domain and -2-deficient and CC/CC embryos establish that
and the Twist box, a newly identified antiosteogenic Twist proteins’ antiosteogenic function affects bones
domain present in the two Twist proteins, provides the ossifying either through an intramembranous or an en-
molecular basis for this inhibition. Eventually, the de- dochondral process. Although no premature ossifica-
crease of Twist genes’ expression triggers osteoblast tion outside the skull has been noted in Twist-1/ em-
differentiation defined by expression of genes down- bryos, one cannot exclude that a systematic analysis
stream of Runx2. This study demonstrates also that of Osteocalcin expression throughout the skeleton of
the molecular defect in Saethre-Chotzen syndrome, a these mutant mice may reveal premature osteoblast dif-
skeletal dysplasia caused by haploinsufficiency at the ferentiation. That premature osteoblast differentiation
takes place in the CC/CC embryos suggests that it is aTWIST locus, is a premature activity of Runx2.
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Figure 8. Chondrocyte Development in CC/CC Mice
(A) In situ hybridization for 1(II) collagen (Aa–Ah), Ihh (Ai–Ap), and 1(X) collagen (Aq–Ax) at E14 (Aa, Ae, Ai, Am, Aq, and Au), 15 (Ab, Af, Aj,
An, Ar, and Av), 16 (Ac, Ag, Ak, Ao, As, and Aw), and 18 (Ad, Ah, Al, Ap, At, and Ax) in ribs of CC/CC (Aa–Ad, Ai–Al, and Aq–At) and wt embryos
(Ae–Ah, Am–Ap, and Au–Ax). Normal 1(II) collagen and Ihh expression while 1(X) collagen is increased in E14 and E15 CC/CC ribs.
(B) A current model of osteoblast differentiation during development. Runx2 is the earliest identified factor required for osteoblast differentiation.
Its function is, however, transiently inhibited by Twists whose decrease in expression determines when osteoblast differentiation can occur.
likely possibility. This negative regulation of osteoblast after birth, Twist proteins inhibit NF-B activity by inter-
acting with RelA and that this function is not mediated bydifferentiation could also be achieved by Twist-1 to-
gether with Twist-2, since they are coexpressed in most their bHLH domains. Surprisingly, although this Twist-2
function also requires its C terminus, NF-B’s DNA bind-developing skeletal elements. This could be tested by
generating CC/CC; Twist-2 null double mutant mice, ing ability was not affected by Twist (Sosic et al., 2003).
This lack of DNA binding inhibition contrasts with whatprovided they live. The fact that the Twist box is present
only in Twist-1 and -2 indicates that only these two we observed in the case of Runx2. At the present time,
the molecular basis for this difference in the mode ofproteins can delay osteoblast differentiation early during
development through the mechanism described here. action of Twist is not fully understood. Ectopic expres-
sion of Twist-1 in cell culture experiments inhibits mus-
cle gene expression (Hebrok et al., 1994; Spicer et al.,Twist Functions and Twist Domains
The bHLH domain of Twist proteins is dispensable for 1996), and Twist-1 can inhibit MyoD’s DNA binding abil-
ity and Mef2’s transactivating function in vitro. Unliketheir antiosteogenic function. It was recently shown that,
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Recombinant Proteinsthat which is the case for its antiosteogenic actions or
GST-fusion proteins were isolated from bacterial lysate using gluta-its inhibition of NF-B, this Twist antimyogenic function
thione beads, and His-tagged proteins were isolated from bacterialrequires both its bHLH and C terminus domains (Spicer
lysate using the Talon system (Clontech) according to manufactur-
et al., 1996). These findings and our results suggest that ers’ directions.
different functions exerted by the Twist proteins may Pull-Down Assays
Fifty micrograms of GST-fusion protein was incubated with 400 guse the same domains of the proteins. Further in vivo-
His-tagged protein and glutathione beads. The beads were thendirected mutagenesis will allow us to address the re-
washed three times and boiled in SDS-PAGE loading buffer. Eluatesspective role of each domain of the Twist proteins in
were subjected to SDS-PAGE, transferred to nitrocellulose mem-their various functions and, in particular, which functions
brane, and immunoblotted using appropriate antibody. Efficiency
are controlled by the Twist box. was calculated by comparing known amounts of GST-Runx2 and
His-Twist to eluted GST-Runx2 and His-Twist-1 followed by correct-
Experimental Procedures ing the percentage of His-Twist-1 bound to the beads by the amount
of GST-Runx2 bound. For gel retardation assay (GRA), labeled dou-
Mutant Animals ble-stranded oligonucleotides were prepared and GRA performed
Twist-1- and Twist-2-deficient mice have been described (Chen and as described (Ducy and Karsenty, 1995), and His-Twist proteins
Behringer, 1995; Sosic et al., 2003). Genotyping was performed by were added to the GRA reaction and incubated on ice for 30 min
PCR analysis of genomic DNA. The Charlie Chaplin (CC) mutation prior to loading onto a 5% acrylamide gel.
arose in the first generation offspring of ENU-treated males. Eight-
week-old C57BL/6J males were injected intraperitoneally (100 mg
AcknowledgmentsENU/kg) weekly for 3 weeks. The polydactyly phenotype of CC/
was observed in 1 of 905 G1 animals produced from these treated
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